| Target Price | CHF10.20 |
| Price | CHF5.45 |
| Potential |
87.16%
register free of charge
|
| Number of Estimates | 9 |
|
9 Analysts have issued a price target DocMorris 2026 .
The average DocMorris target price is CHF10.20.
This is
87.16%
register free of charge
CHF18.10
232.04%
register free of charge
CHF5.96
9.34%
register free of charge
|
|
| A rating was issued by 14 analysts: 8 Analysts recommend DocMorris to buy, 5 to hold and 1 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the DocMorris stock has an average upside potential 2026 of
87.16%
register free of charge
|
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Billion CHF | 1.02 | 1.15 |
| 4.91% | 12.58% | |
| EBITDA Margin | -5.65% | -4.06% |
| 42.87% | 28.20% | |
| Net Margin | -9.56% | -9.64% |
| 212.66% | 0.82% |
10 Analysts have issued a sales forecast DocMorris 2025 . The average DocMorris sales estimate is
This results in the following potential growth metrics:
10 Analysts have issued an DocMorris EBITDA forecast 2025. The average DocMorris EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
10 DocMorris Analysts have issued a net profit forecast 2025. The average DocMorris net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share CHF | -4.06 | -2.30 |
| 217.00% | 43.35% | |
| P/E | negative | |
| EV/Sales | 0.31 |
10 Analysts have issued a DocMorris forecast for earnings per share. The average DocMorris EPS is
This results in the following potential growth metrics and future valuations:
| Analyst | Rating | Action | Date |
|---|---|---|---|
| JEFFERIES |
Locked
➜
Locked
|
Locked | Sep 10 2025 |
| BERENBERG |
Locked
➜
Locked
|
Locked | Aug 20 2025 |
| BAADER HELVEA EQUITY RESEARCH |
Locked
➜
Locked
|
Locked | Aug 19 2025 |
| JEFFERIES |
Locked
➜
Locked
|
Locked | Jul 17 2025 |
| JEFFERIES |
Locked
➜
Locked
|
Locked | Jul 16 2025 |
| BERENBERG |
Locked
➜
Locked
|
Locked | Jul 01 2025 |
| BERENBERG |
Locked
➜
Locked
|
Locked | Jun 30 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
JEFFERIES:
Locked
➜
Locked
|
Sep 10 2025 |
|
Locked
BERENBERG:
Locked
➜
Locked
|
Aug 20 2025 |
|
Locked
BAADER HELVEA EQUITY RESEARCH:
Locked
➜
Locked
|
Aug 19 2025 |
|
Locked
JEFFERIES:
Locked
➜
Locked
|
Jul 17 2025 |
|
Locked
JEFFERIES:
Locked
➜
Locked
|
Jul 16 2025 |
|
Locked
BERENBERG:
Locked
➜
Locked
|
Jul 01 2025 |
|
Locked
BERENBERG:
Locked
➜
Locked
|
Jun 30 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


